معرفی
Dr Emilio Fernandez-Egea is a clinical academic and part-time Assistant Professor at the Department of Psychiatry, University of Cambridge. He serves as an Honorary Consultant Psychiatrist at Cambridgeshire and Peterborough NHS Foundation Trust, leading the treatment-resistant schizophrenia unit and Cambridge Psychosis Centre. His research bridges schizophrenia pathophysiology with clinical care innovation, focusing on negative symptoms, antipsychotic side effects, and metabolic complications.
- Key research areas: negative symptoms neuroscience, clozapine pharmacovigilance, metabolic risk prediction in psychosis
- Active in international clozapine optimization guidelines
Recent publications emphasize clozapine safety, negative symptom heterogeneity, and systemic links between schizophrenia and inflammation/ageing. He collaborates with multidisciplinary teams across institutions like the University of Cambridge, University of Bristol, and Hospital Clinic Barcelona.
As Deputy Editor for British Journal of Psychiatry and Spanish Journal of Psychiatry and Mental Health, he contributes to academic discourse while supervising PhD students and mentoring junior researchers.
